Pricing Log in Create free account

OKYO Pharma Limited Sponsored ADR (OKYO) vs Pelthos Therapeutics Inc. (PTHS)

OKYO Pharma Limited Sponsored ADR and Pelthos Therapeutics Inc. are both Biotechnology companies. OKYO Pharma Limited Sponsored ADR and Pelthos Therapeutics Inc. are of similar size ($77.6M and $75.1M). OKYO Pharma Limited Sponsored ADR has the higher net margin (0.00% vs −199.5%) and the higher return on invested capital (0.00% vs −82.3%). Across the 12 metrics below, OKYO Pharma Limited Sponsored ADR leads on 7 and Pelthos Therapeutics Inc. on 5.

Valuation

Metric OKYO PTHS Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.65 9.71
P/B 86.44 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2.75 9.21
Earnings yield 0.00% (142.54%) (33.15%)
Free cash flow yield (0.89%) (59.72%) (25.50%)

Profitability

Metric OKYO PTHS Biotechnology median
Gross margin 0.00% 78.59% 65.16%
Operating margin — (133.42%) 0.00%
Net margin 0.00% (199.50%) 0.00%
Free cash flow margin 0.00% (98.37%) 0.00%
Return on equity 0.00% 2,161.07% (56.36%)
Return on assets 0.00% (125.04%) (48.04%)
Return on invested capital 0.00% (82.34%) 0.00%

Growth

Metric OKYO PTHS Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (101.34%) (61.12%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric OKYO PTHS Biotechnology median
Debt to equity 0.00 (46.58) 0.00
Current ratio 2.43 1.98 4.72
Net debt to EBITDA 2.42 (0.45) 0.96

Dividend

Metric OKYO PTHS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OKYO PTHS Biotechnology median
Market cap 75.05m 77.57m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack